U.S. Professional Services Stock News

In recent days, Vital Farms has attracted heightened investor attention as analysts highlight expected earnings growth and reference its track record of beating revenue and earnings estimates. Amid this increased focus, a bullish thesis emphasizing Vital Farms’ premium brand positioning and resilience to egg price volatility has become a key talking point for investors. We’ll now examine how growing optimism around Vital Farms’ earnings outlook influences its investment narrative and...

Blue Bird has proposed an amendment to its certificate of incorporation that would limit the liability of certain officers for breaches of fiduciary duty. The change would be implemented through corporate bylaw updates, subject to shareholder approval. The proposal focuses on reshaping how accountability and legal exposure for specific executives are defined within the company. For investors watching NasdaqGM:BLBD, this governance move sits alongside a share price of $51.06 and recent...

HCA Healthcare (NYSE:HCA) is rolling out AI-driven programs across its hospital network to improve clinical workflows, revenue cycle processes, and patient care. The company recently expanded its collaboration with GE Healthcare to develop an AI-enabled fetal heart rate monitoring tool for use in labor and delivery. Multiple HCA hospitals have received recent recognition for clinical excellence, including placements on national "Best Hospitals" lists. HCA Healthcare, one of the largest...

If you are wondering whether General Electric's share price still offers value after its run, this article walks through what the current numbers may be telling you. GE closed at US$308.71, with returns of 4.6% over the last 7 days, a 3.8% decline over the last 30 days, a 3.8% decline year to date, and gains of 52.1% over 1 year, around 4x over 3 years and more than 4x over 5 years. Recent coverage has focused on General Electric's progress as a focused industrial company and investor...

Owlet, Inc. ( NYSE:OWLT ) shareholders have seen the share price descend 25% over the month. But that doesn't change...

Unsurprisingly, Carnival Corporation & plc's ( NYSE:CCL ) stock price was strong on the back of its healthy earnings...

Everspin Technologies (MRAM) is drawing fresh attention after Avalanche Technology filed a patent infringement lawsuit and a related US International Trade Commission complaint focused on Everspin’s Spin-transfer Torque MRAM product line. See our latest analysis for Everspin Technologies. The lawsuit arrives at a time when Everspin’s share price has shown strong momentum, with a 30 day share price return of 31.61% and a year to date share price return of 31.61%, while the 1 year total...

Acadia Healthcare Company reappointed Debra K. Osteen as Chief Executive Officer and board director after the departure of Christopher H. Hunter. Activist investor Engine Capital is urging the company to consider a review of options, including a potential sale or aggressive share buybacks. The leadership change and investor pressure come as the company trades at a share price of $13.21 under the ticker NasdaqGS:ACHC. For investors watching NasdaqGS:ACHC, this leadership reset lands at a...

Event context and why Flowco is on the radar Flowco Holdings (FLOC) has been drawing attention after recent share price moves, with the stock last closing at $21.16 and posting a month and past 3 months return that stands out in its recent history. See our latest analysis for Flowco Holdings. Recent trading has been strong in the short term, with a 30 day share price return of 11.25% and a 90 day share price return of 31.51%, although the 1 year total shareholder return of 24.56% decline...

Tronox Holdings plc recently issued fourth-quarter 2025 guidance, projecting US$730 million in revenue, and announced the permanent closure of its 46,000-metric-ton-per-year TiO2 plant in Fuzhou, China due to weak domestic demand and rising sulfur costs. The company expects to incur US$60–80 million in restructuring and related charges but targets annual cost savings exceeding US$15 million while maintaining its ability to serve customers through its broader global manufacturing...

In January 2026, AXT, Inc. announced that its board had determined Leonard J. LeBlanc to be independent under Nasdaq rules and appointed him Chair of the Audit Committee, with former chair Jesse Chen remaining as a committee member. This governance shift comes as AXT’s role as a key Indium Phosphide wafer supplier to AI-driven data centers has drawn heightened investor attention. Against this backdrop, we’ll examine how Mr. LeBlanc’s move to independent Audit Committee Chair influences AXT’s...

If you are wondering whether Morgan Stanley's recent share price puts it at a premium or still leaves some value on the table, this article is for you. The stock most recently closed at US$185.10, with returns of 1.8% over 7 days, 1.8% over 30 days, 1.8% year to date, 38.6% over 1 year, 106.6% over 3 years and 192.6% over 5 years. Recent coverage of large U.S. financial institutions has focused on how capital markets activity, trading volumes and wealth management trends are influencing...

Wondering whether PHINIA's share price still offers value after a strong run, or if you might be late to the story? This article focuses squarely on what the current valuation is really telling you. PHINIA's share price last closed at US$69.80, with returns of 1.5% over the past 7 days, 8.0% over the last month and year to date, and 45.6% over the past year. These figures can change how investors think about both upside potential and risk. Recent coverage around PHINIA has focused on its...

First Hawaiian, Inc. recently reported full-year 2025 results showing higher net interest income of US$663.74 million and net income of US$276.27 million, alongside a quarterly dividend of US$0.26 per share payable on February 27, 2026 to shareholders of record on February 13, 2026. The board also completed a prior US$100.25 million buyback and authorized a new US$250 million repurchase program, underscoring a focus on returning capital while credit costs, including US$5.0 million of...

Why WESCO International is on investors’ radar today WESCO International (WCC) has drawn fresh interest after its recent share move, with the stock closing at $297.80. Investors are weighing this price against the company’s fundamentals and longer term return record. See our latest analysis for WESCO International. The recent 18.1% 1 month share price return at a last close of $297.80 sits alongside a 66% 1 year total shareholder return. This points to strong positive momentum rather than a...

In recent days, Nutanix was downgraded by multiple major analysts, who shifted their ratings to more neutral stances amid questions about near-term growth visibility. This tension between cautious short-term views and still-supportive longer-term assessments offers a nuanced window into how the market is reassessing Nutanix’s outlook. Next, we’ll examine how these concerns about slowing growth momentum may influence Nutanix’s broader investment narrative and investor expectations. Find...

Demand for AI-driven data centers is surging globally, driven by the widespread adoption of artificial intelligence across various sectors such as enterprise, logistics, finance, and industrial operations. This trend is reshaping commercial real estate as these data centers, requiring substantial electrical capacity and advanced infrastructure, become foundational rather than peripheral assets. Corniche Capital, led by David Ebrahimzadeh, is focusing its investment strategies on AI-capable...

EDAP TMS S.A. ( NASDAQ:EDAP ) shares have continued their recent momentum with a 32% gain in the last month alone...

AGCO (AGCO) is back in focus after reporting third quarter 2025 results that topped forecasts on both EPS and revenue, while also adopting new management compensation plans and keeping its regular dividend intact. See our latest analysis for AGCO. The latest 1 month share price return of 8.34% and 3 month gain of 9.53% put AGCO at US$114.67, with a 1 year total shareholder return of 15.10% contrasting with a weaker 3 year total shareholder return of a 6.22% decline. This suggests recent...

Why First Busey (BUSE) Is Back on Investors’ Radar First Busey (BUSE) has attracted fresh attention after releasing fourth quarter and full year 2025 results, a leadership change, and an update on its long running share repurchase program. See our latest analysis for First Busey. The earnings release, leadership change and share repurchase update have come alongside a 12.27% 90 day share price return and a 39.40% five year total shareholder return, suggesting momentum has been building...

Louisiana-Pacific Corporation has announced that, effective February 19, 2026, long-time director F. Nicholas Grasberger III will become independent Chairperson as current Chair and CEO W. Bradley Southern retires from the Board, while President and CEO-elect Jason P. Ringblom joins as a Class III director and two other directors plan to retire in May 2026. This leadership reshaping, pairing an independent Chair with an internal successor as CEO, signals a clearer separation of oversight and...

The Beachbody Company, Inc. ( NASDAQ:BODI ) shares have continued their recent momentum with a 31% gain in the last...

If you are wondering whether NIKE's current share price offers genuine value or just looks cheap on the surface, this article is designed to walk you through the key numbers in a clear and practical way. NIKE shares last closed at US$62.18, with returns of 4.3% decline over 7 days, 1.7% decline over 30 days, 1.7% decline year to date, 16.9% decline over 1 year, 47.8% decline over 3 years and 53.4% decline over 5 years. This raises questions about how the market is currently viewing its...

Analyst optimism and product pipeline in focus Krystal Biotech (KRYS) is back in the spotlight after several major research houses highlighted its potential to evolve into a multi product company, pointing to ophthalmic candidates KB803 and KB801 and the planned geographic expansion of Vyjuvek. See our latest analysis for Krystal Biotech. Those upbeat analyst views have landed alongside strong recent momentum, with Krystal Biotech’s share price at $282.27 and a 30 day share price return of...